M. Lallement

Papers

Total Citations

H-Index

About

M. Lallement is a pioneering researcher in the field of oncological radiotherapy, with a primary focus on the integration of advanced stereotactic techniques with systemic therapies for breast cancer treatment. Their most notable contribution is the development and clinical validation of robotic stereotactic radioablation combined with neoadjuvant chemotherapy for breast tumors, a groundbreaking approach that enhances precision in tumor targeting while minimizing damage to surrounding healthy tissue. This work, published in 2009, has garnered over 30 citations, reflecting its influence on the evolution of non-invasive cancer treatments. Lallement’s research bridges the gap between radiation oncology and surgical oncology, offering patients a less invasive alternative to traditional mastectomy or lumpectomy. Their achievements include pioneering protocols that have been adopted in early-stage breast cancer trials, demonstrating improved tumor response rates and reduced toxicity. By advancing the synergy between radioablation and chemotherapy, Lallement has contributed to a paradigm shift in breast cancer management, making them a key figure in the ongoing effort to personalize and refine oncological interventions. Their work continues to inspire further studies on stereotactic body radiotherapy in multimodal treatment regimens.